Stock listing

Merck Kgaa

Selected listing: MER · SIX · CHF · CH

Merck Kgaa (SIX Swiss: MER), Health Technology. Latest release Sep 23, 2026: Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany.

MER:SIXCHFCHUpdated October 2, 2026

Ticker: SIX Swiss: MER
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: SIX Swiss
Currency: CHF

Latest news from Merck Kgaa

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

September 23, 2026

IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players

September 8, 2026

The Hashgraph Group and Merck with support from PwC Germany develop solution for cocoa traceability and digital product passports

September 8, 2026

Münchener Rückversicherungs-Gesellschaft AG: Mari-Lizette Malherbe, buy

August 10, 2026

Merck Opens BioReliance® Testing Facility in Darmstadt, Germany to Support Drug Product Release in Europe

July 16, 2026

All Merck Kgaa news →

Events

Replays

Merck Kgaa (MKGAF) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 08:00 AM ET
Watch
Merck Kgaa (MKGAF) Q1 2026 Earnings Call
Wed, May 13, 2026 · 08:00 AM ET
Watch
Merck Kgaa (MKGAF) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 04:00 AM ET
Watch

Research Merck Kgaa

Merck Kgaa company profile

View the public company page for Merck Kgaa on 6ix.

Merck Kgaa news

Read company news and market updates connected to Merck Kgaa.

Merck Kgaa investor events

Find investor webinars, events, and replay context for Merck Kgaa.